查看购物车
  • Traditional Chinese
  • English
  • Japanese
封面
市场调查报告书
商品编码
1844121

长读长定序市场按产品/服务、技术、应用和最终用户划分 - 全球预测 2025-2032

Long Read Sequencing Market by Product & Service, Technology, Application, End User - Global Forecast 2025-2032
出版日期: | 出版商: 360iResearch | 英文 187 Pages | 商品交期: 最快1-2个工作天内

价格

※ 本网页内容可能与最新版本有所差异。详细情况请与我们联繫。

预计到 2032 年，长读定序市场将成长至 58.2348 亿美元，复合年增长率为 27.01%。

主要市场统计数据
基准年 2024 8.598亿美元
预计年份：2025年 10.9712亿美元
预测年份：2032年 5,823,480,000 美元
复合年增长率 (%) 27.01%

这是一篇简洁而权威的介绍，解释了长读定序如何发展成为一个策略平台，正在重塑研究、诊断和应用基因组学。

长读长定序已从一项专门的研究能力转变为一个策略平台，重塑了基因组研究、临床转化流程和应用生命科学。该技术能够分析复杂的基因组区域，检测长单倍型中的等位基因同源性，并检测天然分子中的结构变异和表观遗传标记，为短读长测序方法无法可靠解决的应用开闢了无限可能。因此，研究机构、诊断实验室和企业正在重新评估其技术架构、工作流程和供应商关係，以充分利用长读长定序带来的科学和营运优势。

同时，化学、孔隙工程、仪器设计和生物资讯学的进步正在简化样品製备，同时提高读取的准确性和通量。这些技术进步，加上分析工具和云端工作流程的普及，降低了进入门槛，并将使用者群体扩展到专业定序中心之外。因此，各机构正从概念验证研究转向在肿瘤学、病原体监测、作物改良和精准医疗等领域常规应用长读长定序技术。

从实验级操作过渡到生产级操作需要关注可重复性、法规遵循和供应连续性。因此，希望利用长读长定序技术的实验室必须整合稳健的资料管理、验证实务和与供应商无关的品管，以确保科学研究成果能够转化为实际营运效益和可靠的临床或监管产出。

展望未来，探讨技术、商业性和工作流程的转变如何重新定义各领域的长读长定序应用和营运模式。

长读长定序领域正经历显着的变革，这主要得益于技术的成熟、工作流程的整合以及终端使用者需求的不断变化。硬体和化学技术的进步提高了单次定序的准确性和运作稳定性，而模组化的仪器架构则实现了从桌上型到高通量中心的可扩展通量。同时，即时碱基辨识和天然表观遗传检测技术的出现，催生了新的应用场景，在这些场景中，快速週转和多层次的分子资讯至关重要。

同时，软体生态系统正从客製化的学术脚本转向强调可復现性、可復现流程和法规遵循的企业级解决方案。云端原生分析框架、容器化和标准化API实现了跨平台互通性，降低了临床实验室和合约研究组织（CRO）采用长读长工作流程的门槛。此外，耗材的商品化以及试剂生产中对永续性的关注也正在影响筹资策略和长期营运成本。

这种转变也体现在市场动态中，供应商正在使其商业模式多元化，包括提供仪器服务、订阅式耗材计划以及将定序与生物资讯学和维护相结合的整合服务。随着各机构重新思考其长期投资，关注点正转向总体拥有成本、生命週期支援以及技术合作伙伴提供符合监管和临床级要求的检验工作流程的能力。

对截至2025年美国累积关税如何改变定序生态系统中的筹资策略、供应韧性和供应商应对措施进行深入评估

美国在2025年前逐步实施的累积关税政策，为长读长定序生态系统的采购、供应链韧性和筹资策略带来了新的挑战。进口设备和关键试剂关税的提高迫使企业重新评估供应商关係和库存策略，以降低成本波动和前置作业时间风险。为此，许多相关人员优先考虑供应商多元化，为流动池和专用试剂套件等关键耗材建立缓衝库存，并重新评估服务合约以锁定价格和交货时间。

为了降低跨境关税的影响，製造商和经销商纷纷调整策略，探索在岸组装、区域配送中心以及与当地製造商建立合作关係。对顾客而言，关税环境使产品生命週期规划更加复杂。由于负责人需要进行更全面的总成本分析，并寻求签订多年服务协议以管理关税实施后的营运预算，采购週期也随之延长。同时，一些供应商透过价格策略来维持装置量的忠诚度，从而承担了部分成本上涨；而另一些供应商则加快了对区域製造的投资，以重获竞争优势并缩短供应链。

整体而言，关税凸显了供应链透明度、合约弹性和情境规划的策略价值。积极主动模拟关税风险、协商弹性条款并制定替代筹资策略的机构，将更有利于维持研究的连续性、保障临床工作流程，并确保产品开发和发现的进度符合市场竞争要求。

深入分析并综合产品、技术、应用和最终用户等维度上的细微细分动态，为策略优先排序提供基础。

细分市场层面的动态揭示了产品和服务、技术、应用以及最终用户群体之间存在的差异化驱动因素，这些差异对于策略定位至关重要。在产品和服务领域，耗材（包括流动池、套件和试剂）的经常性收入仍然是业务运营的核心考虑因素，因为它们的可靠性和供应的连续性直接影响通量和实验的可重复性。对定序系统和配套附件的投资决定了资本规划週期，而生物资讯服务、数据分析软体和维护服务则决定了长期营运支援和监管合规性。

在各个技术领域，奈米孔定序已发展成为一种高度可携式、即时回应的解决方案，适用于现场部署和快速监测；而单分子即时定序则凭藉其高单次读取准确率和环状共识方法，巩固了其市场地位。合成长读长定序策略继续为某些基因组组装工作和大规模基因组计划提供经济高效的替代方案，在这些计画中，从连接读段重建远距资讯具有优势。

在农业基因组学中，长读长定序可用于结构变异检测和复杂性状定位；在癌症基因组学中，长程定相用于揭示肿瘤异质性；在临床研究中，长程定相用于转化研究中的全面变异检测；在微生物基因组学中，长读长测序用于质体解析和疫情追踪。不同的最终用户有不同的重点：学术中心专注于方法创新和新的应用案例；临床诊断实验室优先考虑验证、通量和合规性；受託研究机构为多个客户提供承包测序服务；政府和监管机构侧重于监测和标准化；而製药和生物技术公司则将长读长测序整合到其靶点发现和生物标誌物检验工作中。

区域比较情报观点，展现了全球主要区域在采用驱动因素、法律规范和商业生态系统方面的差异

区域动态反映了研究基础设施、法规环境和商业生态系统的差异，进而影响技术的应用管道和竞争重点。在美洲，强大的学术研究网络、密集的临床实验室活动以及成熟的供应商基础正在加速高精度、长读长定序技术在肿瘤学、神经基因组学和微生物监测领域的应用。该地区也展现出成熟的公私合营模式，将定序仪整合到公共卫生倡议和转化计画中。

在欧洲、中东和非洲，监管协调工作和泛欧联盟正在推动对参考基因组、监测网路和跨境资料共用的协调投资。该地区的研究资助模式通常强调共享基础设施和标准化通讯协定，从而影响采购週期以及对检验的工作流程和符合规范的软体的需求。多语言市场和多元化的医疗保健系统凸显了在地化支援和跨司法管辖区监管专业知识的重要性。

在亚太地区，资本的快速投入、国内製造能力的扩张以及农业基因组学和感染疾病监测领域的活性化，正在加速技术的应用和创新。区域参与企业通常优先考虑能够兼顾吞吐量和成本效益的可扩展平台，而区域内的跨境合作正在促进生态系统的发展。这些区域差异提示了市场进入策略、伙伴关係模式以及对本地支援和供应链韧性的投资重点方向。

企业行为的策略性回顾，揭示了平台创新、整合服务和不断演进的商业模式如何塑造竞争优势。

长读长定序领域的企业策略正围绕着几个共同的主题：提昇平台效能、优化耗材生命週期管理、整合软体和服务以及建立合作伙伴关係。主要仪器供应商正增加对化学创新和孔径设计的投入，以降低误差率并提高通量，同时扩展仪器外形尺寸，以适应更广泛的实验室空间。除了硬体方面的进步，各公司也正在加速开发分析套件和託管服务，以消除临床和工业用户在使用经过检验的端到端工作流程时遇到的障碍。

同时，商业模式也变得更灵活。基于订阅的仪器使用、试剂捆绑销售和全面的支援服务包正逐渐成为传统资本购买模式的可行替代方案。试剂生产商、云端分析提供者和学术联盟之间的策略伙伴关係正被用于拓展目标市场并加速特定应用领域的检验，例如肿瘤基因组检测、作物基因组分析流程和病原体监测通讯协定。服务供应商和合约研究组织（CRO）正在扩展其能力，以提供专业的长读长定序服务，使客户能够在确保资料管治和品质的前提下外包定序和分析工作。

最后，企业正优先考虑供应链多元化和本地化生产，以降低关税和物流风险。那些拥有强大的研发蓝图、透明的服务等级协定和在地化支援体系的企业，对寻求长期伙伴关係的大型机构和企业客户而言，正变得越来越有吸引力。

为平衡供应链韧性、生物资讯投资、监管参与和以客户为中心的商业模式，提出切实可行的建议

产业领导者应采取组合策略，兼顾短期业务永续营运和长期策略差异化。首先，他们应透过建立关键耗材（如流动池和特种试剂）的多源采购策略来增强供应链韧性，并在适当情况下签订多年期合同，同时评估区域分销或组装方案，以降低跨境关税波动带来的风险。其次，他们应优先投资于生物资讯学和数据管理。标准化、检验的流程和健全的资料管治能够加速临床应用，并支持跨机构合作。

第三，我们透过为学术研究机构提供灵活的采购选项、为临床诊断客户提供检验的承包解决方案以及为委外研发机构提供可扩展的服务包，使我们的产品和商业模式与终端用户的独特需求保持一致。第四，我们积极与监管相关人员沟通并参与标准化项目，以确保新的工作流程符合不断变化的合规要求，并缩短临床验证所需的时间。第五，我们投资于培训和现场支持，以减少实施过程中的阻力。为实验室人员和转化科学家提供的实践培训可以提高工作效率并降低错误率。

将这些措施结合起来，将使各组织能够利用其科学优势，确保营运连续性，并将技术领先地位转化为其研究项目、临床服务和产品开发平臺的可衡量成果。

对用于综合分析技术趋势、相关人员观点和市场区隔等方面的洞察的依证和分析过程进行透明描述。

本执行摘要的研究结合了结构化的二手资料分析、专家访谈和跨来源检验，以确保其严谨性和有效性。二手资料分析包括对同行评审文献、专利活动、公开产品公告、监管文件和技术白皮书的系统性回顾，旨在描绘技术发展轨迹和创新热点。这些资讯来源被整合起来，用于识别新兴的绩效基准、工作流程转变和商业模式创新。

为了补充文献综述，我们对实验室主任、技术采用者、采购负责人和行业策略家进行了定性访谈，以将技术趋势与实际营运情况和采购限制联繫起来。访谈内容帮助我们解读了供应商策略、顾客痛点以及关税主导的供应链转型所带来的实际影响。我们对来自资讯来源的研究结果进行了三角验证，以减少偏差并识别反覆出现的主题。

最后，我们应用了一个细分框架，从产品类型、技术类型、应用领域和最终用户画像等方面深入了解市场。调查方法的局限性包括设备性能声明的不断变化以及专有技术发布可能存在的延迟。因此，该调查方法强调假设的透明度，并鼓励对投资决策和采购承诺进行后续检验。

综合各项研究结果，重点阐述为最大限度发挥长读长定序创新技术的价值所需的策略要务与营运重点。

长读长定序正处于曲折点，技术进步、应用拓展和商业性实践的演进将为研究机构、临床实验室和商业性生命科学组织创造持久的策略价值。它能够提供远距基因组资讯、原生检测表观遗传标记并解析结构复杂性，这将推动肿瘤学、微生物监测、农业育种和转化检验等领域的进步。结合对经过验证的分析技术和稳健供应链的投资，这些技术优势将转化为实际的营运和策略效益。

然而，要充分发挥这种潜力，需要采取检验行动，例如优先考虑受法规环境的工作流程、在耗材采购中建立冗余机制，以及投资于能够确保可重复性和合规性的软体和服务。那些将采购、研发计画和伙伴关係策略与这些必要条件相契合的相关人员，最能从中获取持久价值。相反，那些延迟将长读长数据整合到其流程中的机构，则可能在製定日益具有竞争力的研究和临床项目方面落后于竞争对手。

长读定序的发展轨迹将继续受到化学和资讯学创新、商业模式的适应性以及使用者和供应商在标准、检验和培训方面的合作能力的影响，从而支持其广泛而可靠的应用。

目录

第一章：序言

第二章调查方法

第三章执行摘要

第四章 市场概览

第五章 市场洞察

  • 将奈米孔定序与即时数据分析流程结合，用于快速疾病监测
  • 开发一种高保真长读长定序平台，实现精确的相位测定和异构体分离。
  • 扩大可携式定序仪的规模，用于偏远地区的现场病原体检测和疫情监测
  • 利用单分子长读长定序进行全面的表观遗传学和甲基化谱分析
  • 将基于 CRISPR 的富集策略与长读长定序相结合，用于标靶突变检测
  • 长读长技术在元基因组组组装和抗生素抗药性基因鑑定的新应用
  • 利用人工智慧演算法增强超长读取资料集中的纠错能力

第六章美国关税的累积影响，2025年

第七章 人工智慧的累积影响，2025年

8. 长读长定序市场（依产品和服务划分）

  • 消耗品
    • 流动池
    • 套件
    • 试剂
  • 装置
    • 配件
    • 定序系统
  • 软体和服务
    • 生物资讯服务
    • 数据分析软体
    • 维护服务

9. 按技术分類的长读长定序市场

  • 奈米孔定序
  • 单分子即时定序
  • 合成长读定序

第十章 依应用分類的长读长定序市场

  • 农业基因组学
  • 癌症基因体学
  • 临床研究
  • 微生物基因体学

第十一章 依最终用户分類的长读长定序市场

  • 学术的
  • 临床诊断实验室
  • 合约研究组织
  • 政府和监管机构
  • 製药和生物技术

第十二章 各地区的长读长定序市场

  • 美洲
    • 北美洲
    • 拉丁美洲
  • 欧洲、中东和非洲
    • 欧洲
    • 中东
    • 非洲
  • 亚太地区

第十三章 长读长定序市场（依组别划分）

  • ASEAN
  • GCC
  • EU
  • BRICS
  • G7
  • NATO

第十四章 各国长读长定序市场

  • 美国
  • 加拿大
  • 墨西哥
  • 巴西
  • 英国
  • 德国
  • 法国
  • 俄罗斯
  • 义大利
  • 西班牙
  • 中国
  • 印度
  • 日本
  • 澳洲
  • 韩国

第十五章 竞争格局

  • 2024年市占率分析
  • FPNV定位矩阵，2024
  • 竞争分析
    • Pacific Biosciences of California, Inc.
    • Oxford Nanopore Technologies Limited
    • Illumina, Inc.
    • QIAGEN NV
    • F. Hoffmann-La Roche Ltd.
    • BGI Genomics Co., Ltd.
    • Genapsys, Inc.
    • Thermo Fisher Scientific Inc.
    • Hitachi High-Technologies Corporation
    • Element Biosciences, Inc.
Product Code: MRR-A26E0E574570

The Long Read Sequencing Market is projected to grow by USD 5,823.48 million at a CAGR of 27.01% by 2032.

KEY MARKET STATISTICS
Base Year [2024] USD 859.80 million
Estimated Year [2025] USD 1,097.12 million
Forecast Year [2032] USD 5,823.48 million
CAGR (%) 27.01%

A concise and authoritative introduction explaining how long read sequencing has evolved into a strategic platform reshaping research, diagnostics, and applied genomics

Long read sequencing has moved from a specialized research capability into a strategic platform that is reshaping genomics research, clinical translational pipelines, and applied life sciences. The technology's ability to resolve complex genomic regions, phase alleles across long haplotypes, and detect structural variants and epigenetic marks in native molecules has unlocked applications that short-read methods cannot reliably address. As a result, research institutions, diagnostic labs, and industry adopters are re-evaluating technology stacks, workflows, and vendor relationships to capture the scientific and operational advantages offered by long reads.

In parallel, advances in chemistry, pore engineering, instrument design, and bioinformatics have increased read accuracy and throughput while simplifying sample preparation. These technical improvements, together with greater accessibility of analysis tools and cloud-enabled workflows, have lowered barriers to entry and broadened the user base beyond specialist sequencing centers. Consequently, organizations are moving from proof-of-concept studies to routine incorporation of long reads within programs in oncology, pathogen surveillance, crop improvement, and precision medicine.

Transitioning from experimental use to production-grade operations requires attention to reproducibility, regulatory readiness, and supply continuity. Institutions seeking to capitalize on long-read capability must therefore integrate robust data management, validation practices, and vendor-agnostic quality controls to ensure that the scientific gains translate into operational impact and credible clinical or regulatory outputs.

A forward-looking exploration of the technological, commercial, and workflow shifts that are redefining long read sequencing adoption and operational models across sectors

The landscape of long read sequencing is undergoing transformative shifts driven by technological maturation, workflow integration, and evolving end-user expectations. Hardware and chemistry advances have improved per-read accuracy and extended run stability, while modular instrument architectures permit scalable throughput from benchtop deployments to high-capacity centers. At the same time, real-time basecalling and native epigenetic detection have enabled new use cases where rapid turnaround and multi-layered molecular information are essential.

Concurrently, software ecosystems have shifted from bespoke academic scripts to enterprise-grade solutions that emphasize reproducibility, reproducible pipelines, and regulatory compliance. Cloud-native analysis frameworks, containerization, and standardized APIs are enabling cross-platform interoperability and easing barriers for clinical laboratories and CROs to adopt long-read workflows. Moreover, the commoditization of consumables and focus on sustainability in reagent manufacturing are influencing procurement strategies and long-term operating costs.

These changes are also manifesting in market behavior: vendors are diversifying commercial models to include instrument-as-a-service, subscription-based consumable plans, and integrated service offerings that bundle sequencing with bioinformatics and maintenance. As organizations reconsider long-term investments, attention is shifting toward total cost of ownership, lifecycle support, and the ability of technology partners to deliver validated workflows that meet regulatory and clinical-grade requirements.

An incisive assessment of how cumulative U.S. tariff measures through 2025 have reshaped procurement strategies, supply resilience, and vendor responses in the sequencing ecosystem

The cumulative tariff measures introduced in the United States through 2025 have introduced new dimensions to procurement, supply chain resilience, and sourcing strategies across the long read sequencing ecosystem. Increased duties on imported instruments and key reagents have prompted organizations to reassess vendor relationships and inventory policies to mitigate cost volatility and lead-time risk. In response, many stakeholders have prioritized diversification of suppliers, established buffer inventories for critical consumables like flow cells and specialized kits, and re-evaluated service contracts to lock in pricing and delivery windows.

Manufacturers and distributors have adapted by exploring onshore assembly, regional distribution centers, and partnerships with local manufacturers to reduce exposure to cross-border tariff impacts. For customers, the tariff environment has made lifecycle planning more complex: procurement cycles are extending as purchasers perform more thorough total-cost analyses and seek multi-year service agreements to manage post-tariff operating budgets. At the same time, some vendors have absorbed a portion of increased costs through pricing strategies that preserve installed-base loyalty, while others have accelerated investments in regional manufacturing to regain competitive positioning and shorten supply lines.

Overall, tariffs have emphasized the strategic value of supply-chain transparency, contractual flexibilities, and scenario planning. Organizations that proactively model tariff exposures, negotiate flexible terms, and develop alternative sourcing strategies are better positioned to sustain research continuity, protect clinical workflows, and maintain competitive timelines for product development and discovery.

A deep-dive synthesis of nuanced segmentation dynamics across product, technology, application, and end-user dimensions that inform strategic prioritization

Segment-level dynamics reveal differentiated drivers across products and services, technologies, applications, and end-user groups, and these distinctions are critical for strategic positioning. Within product and service segmentation, recurring revenue from consumables-including flow cells, kits, and reagents-remains a central operational consideration because consumable reliability and supply continuity directly affect throughput and experimental reproducibility. Investments in sequencing systems and supporting accessories shape capital planning cycles, whereas bioinformatics services, data analysis software, and maintenance services determine long-term operational support and regulatory readiness.

Across technology segmentation, nanopore sequencing has matured as a highly portable, real-time solution suited to field deployments and rapid surveillance, while single molecule real time sequencing has strengthened its niche where high per-read accuracy and circular consensus approaches are essential. Synthetic long read strategies continue to provide cost-effective alternatives for certain assembly tasks and large-genome projects where reconstructing long-range information from linked reads remains advantageous.

In terms of application, agricultural genomics benefits from long reads for structural variant detection and complex trait mapping, cancer genomics uses long-range phasing to resolve tumor heterogeneity, clinical research leverages comprehensive variant calling for translational studies, and microbial genomics relies on long reads for plasmid resolution and outbreak tracing. End users differ in priorities: academic centers focus on methodological innovation and novel use cases, clinical diagnostic laboratories emphasize validation, throughput, and compliance, contract research organizations offer turnkey sequencing services for multiple clients, government and regulatory bodies concentrate on surveillance and standardization, and pharmaceutical and biotechnology firms integrate long reads into target discovery and biomarker validation workflows.

A comparative regional intelligence perspective capturing how adoption drivers, regulatory frameworks, and commercial ecosystems diverge across major global regions

Regional dynamics are shaping adoption pathways and competitive priorities in distinct ways, reflecting differences in research infrastructure, regulatory environments, and commercial ecosystems. In the Americas, strong academic research networks, a dense concentration of clinical trial activity, and established vendor bases have accelerated adoption of high-accuracy long-read pipelines for oncology, neurogenomics, and microbial surveillance. This region also demonstrates mature public-private collaboration models that integrate sequencing into public health initiatives and translational programs.

In Europe, the Middle East & Africa, regulatory harmonization efforts and pan-European consortia are driving coordinated investments in reference genomes, surveillance networks, and cross-border data sharing. Research funding models in this region often emphasize collaborative infrastructure and standardized protocols, which in turn influence procurement cycles and demand for validated workflows and compliance-ready software. The presence of multiple language markets and diverse healthcare systems increases the importance of localized support and multi-jurisdictional regulatory expertise.

In the Asia-Pacific region, rapid capital deployment, expanding domestic manufacturing capabilities, and intensive activity in agricultural genomics and infectious disease surveillance have accelerated both adoption and innovation. Regional players often prioritize scalable platforms that balance throughput with cost-efficiency, and cross-border collaborations within the region are fostering ecosystem growth. Together, these regional distinctions inform go-to-market approaches, partnership models, and where to focus investments in local support and supply-chain resilience.

A strategic review of corporate behaviors showing how platform innovation, integrated services, and commercial model evolution are shaping competitive advantage

Corporate strategies within the long read sequencing domain are converging around several consistent themes: platform performance improvements, consumable lifecycle management, software and service integration, and collaborative partnerships. Leading instrument vendors are investing in chemistry innovations and pore design to reduce error profiles and improve throughput while expanding instrument form factors to address a broader range of laboratory footprints. Complementary to hardware advances, companies are accelerating development of analysis suites and managed services to remove barriers for clinical and industrial users who require validated, end-to-end workflows.

At the same time, commercial models are becoming more flexible. Subscription-based access to instruments, reagent bundling, and comprehensive support packages are emerging as viable alternatives to traditional capital purchase models. Strategic partnerships-spanning reagent manufacturers, cloud analytics providers, and academic consortia-are being used to extend addressable markets and accelerate application-specific validation, for example in oncology panels, crop genomics pipelines, and pathogen surveillance protocols. Service providers and CROs are expanding capabilities to include long-read-specific offerings, enabling customers to outsource sequencing and analysis while preserving data governance and quality.

Finally, companies are prioritizing supply-chain diversification and regional manufacturing to mitigate tariff exposure and logistics risk. Those that combine robust R&D roadmaps with transparent service level agreements and localized support infrastructures are increasingly attractive to large institutional buyers and enterprise customers seeking long-term partnerships.

Practical and actionable recommendations that balance supply resilience, bioinformatics investment, regulatory engagement, and customer-centric commercial models

Industry leaders should pursue a portfolio approach that balances near-term operational continuity with long-term strategic differentiation. First, strengthen supply-chain resilience by establishing multi-sourcing strategies for critical consumables such as flow cells and specialized reagents, negotiating multi-year commitments where appropriate, and evaluating regional distribution or assembly options to reduce exposure to cross-border tariff volatility. Second, prioritize investments in bioinformatics and data management: standardized, validated pipelines and robust data governance accelerate clinical adoption and support cross-institutional collaborations.

Third, align product and commercial models with distinct end-user needs by offering flexible procurement options for academic laboratories, validated turnkey solutions for clinical diagnostic customers, and scalable service packages for contract research organizations. Fourth, engage proactively with regulatory stakeholders and participate in standards-setting initiatives to ensure that new workflows meet evolving compliance expectations and to reduce time-to-validation for clinical applications. Fifth, invest in training and field support to lower adoption friction; hands-on education for laboratory staff and translational scientists will increase throughput and reduce error rates.

Taken together, these actions will enable organizations to capitalize on scientific advantages, secure operational continuity, and convert technical leadership into measurable outcomes for research programs, clinical services, and product development pipelines.

A transparent explanation of the evidence base and analytic processes used to synthesize technical trends, stakeholder perspectives, and segmentation-aligned insights

The research underpinning this executive summary combines structured secondary analysis, expert interviews, and cross-source validation to ensure rigor and relevance. Secondary analysis included a systematic review of peer-reviewed literature, patent activity, public product announcements, regulatory filings, and technical white papers to map technology trajectories and innovation hotspots. These sources were synthesized to identify emerging performance benchmarks, workflow shifts, and commercial model innovations.

Complementing the literature review, qualitative interviews were conducted with laboratory directors, technology adopters, procurement leads, and industry strategists to ground technical trends in operational realities and procurement constraints. Interview insights informed interpretations of vendor strategies, customer pain points, and the practical implications of tariff-driven supply-chain changes. Findings were triangulated across sources to reduce bias and confirm recurring themes.

Finally, segmentation frameworks were applied to align insights with product categories, technology types, application domains, and end-user profiles. Limitations include the evolving nature of instrument performance claims and potential lag in public disclosures for proprietary developments; accordingly, the methodology emphasizes transparency about assumptions and recommends follow-up validation for investment decisions or procurement commitments.

A concluding synthesis that clarifies the strategic imperatives and operational priorities required to capture the full value of long read sequencing innovations

Long read sequencing stands at an inflection point where technical progress, expanding application breadth, and evolving commercial practices are creating sustained strategic value for research institutions, clinical laboratories, and commercial life-science organizations. The capacity to deliver long-range genomic information, detect epigenetic marks natively, and resolve structural complexity is catalyzing advancements in oncology, microbial surveillance, agricultural breeding, and translational research. When combined with investments in validated analytics and resilient supply chains, these technical strengths translate into tangible operational and strategic benefits.

However, realizing this potential requires deliberate actions: prioritizing validated workflows for regulated settings, building redundancies in consumable sourcing, and investing in software and services that ensure reproducibility and regulatory compliance. Stakeholders that align procurement, R&D planning, and partnership strategies with these imperatives will be best positioned to extract sustained value. In contrast, organizations that delay integration of long-read data into their pipelines risk falling behind in capabilities that increasingly define competitive research and clinical programs.

Ultimately, the trajectory of long read sequencing will continue to be shaped by innovations in chemistry and informatics, by the adaptability of commercial models, and by the ability of users and vendors to collaborate on standards, validation, and training that underpin broad, reliable adoption.

Table of Contents

1. Preface

  • 1.1. Objectives of the Study
  • 1.2. Market Segmentation & Coverage
  • 1.3. Years Considered for the Study
  • 1.4. Currency & Pricing
  • 1.5. Language
  • 1.6. Stakeholders

2. Research Methodology

3. Executive Summary

4. Market Overview

5. Market Insights

  • 5.1. Integration of nanopore sequencing with real-time data analysis pipelines for rapid disease surveillance
  • 5.2. Development of high-fidelity long read platforms enabling accurate phasing and isoform resolution
  • 5.3. Expansion of portable sequencers for in-field pathogen detection and outbreak monitoring in remote areas
  • 5.4. Adoption of single-molecule long read sequencing for comprehensive epigenetic and methylation profiling
  • 5.5. Integration of long read sequencing with CRISPR-based enrichment strategies for targeted variant detection
  • 5.6. Emerging use of long read technology for metagenomic assembly and antibiotic resistance gene identification
  • 5.7. Implementation of artificial intelligence algorithms to enhance error correction in ultra-long read datasets

6. Cumulative Impact of United States Tariffs 2025

7. Cumulative Impact of Artificial Intelligence 2025

8. Long Read Sequencing Market, by Product & Service

  • 8.1. Consumables
    • 8.1.1. Flow Cells
    • 8.1.2. Kits
    • 8.1.3. Reagents
  • 8.2. Instruments
    • 8.2.1. Accessories
    • 8.2.2. Sequencing Systems
  • 8.3. Software & Services
    • 8.3.1. Bioinformatics Services
    • 8.3.2. Data Analysis Software
    • 8.3.3. Maintenance Services

9. Long Read Sequencing Market, by Technology

  • 9.1. Nanopore Sequencing
  • 9.2. Single Molecule Real Time Sequencing
  • 9.3. Synthetic Long Read Sequencing

10. Long Read Sequencing Market, by Application

  • 10.1. Agricultural Genomics
  • 10.2. Cancer Genomics
  • 10.3. Clinical Research
  • 10.4. Microbial Genomics

11. Long Read Sequencing Market, by End User

  • 11.1. Academic
  • 11.2. Clinical Diagnostic Laboratories
  • 11.3. Contract Research Organizations
  • 11.4. Government And Regulatory Bodies
  • 11.5. Pharmaceutical And Biotechnology

12. Long Read Sequencing Market, by Region

  • 12.1. Americas
    • 12.1.1. North America
    • 12.1.2. Latin America
  • 12.2. Europe, Middle East & Africa
    • 12.2.1. Europe
    • 12.2.2. Middle East
    • 12.2.3. Africa
  • 12.3. Asia-Pacific

13. Long Read Sequencing Market, by Group

  • 13.1. ASEAN
  • 13.2. GCC
  • 13.3. European Union
  • 13.4. BRICS
  • 13.5. G7
  • 13.6. NATO

14. Long Read Sequencing Market, by Country

  • 14.1. United States
  • 14.2. Canada
  • 14.3. Mexico
  • 14.4. Brazil
  • 14.5. United Kingdom
  • 14.6. Germany
  • 14.7. France
  • 14.8. Russia
  • 14.9. Italy
  • 14.10. Spain
  • 14.11. China
  • 14.12. India
  • 14.13. Japan
  • 14.14. Australia
  • 14.15. South Korea

15. Competitive Landscape

  • 15.1. Market Share Analysis, 2024
  • 15.2. FPNV Positioning Matrix, 2024
  • 15.3. Competitive Analysis
    • 15.3.1. Pacific Biosciences of California, Inc.
    • 15.3.2. Oxford Nanopore Technologies Limited
    • 15.3.3. Illumina, Inc.
    • 15.3.4. QIAGEN N.V.
    • 15.3.5. F. Hoffmann-La Roche Ltd.
    • 15.3.6. BGI Genomics Co., Ltd.
    • 15.3.7. Genapsys, Inc.
    • 15.3.8. Thermo Fisher Scientific Inc.
    • 15.3.9. Hitachi High-Technologies Corporation
    • 15.3.10. Element Biosciences, Inc.

LIST OF FIGURES

  • FIGURE 1. GLOBAL LONG READ SEQUENCING MARKET SIZE, 2018-2032 (USD MILLION)
  • FIGURE 2. GLOBAL LONG READ SEQUENCING MARKET SIZE, BY PRODUCT & SERVICE, 2024 VS 2032 (%)
  • FIGURE 3. GLOBAL LONG READ SEQUENCING MARKET SIZE, BY PRODUCT & SERVICE, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 4. GLOBAL LONG READ SEQUENCING MARKET SIZE, BY TECHNOLOGY, 2024 VS 2032 (%)
  • FIGURE 5. GLOBAL LONG READ SEQUENCING MARKET SIZE, BY TECHNOLOGY, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 6. GLOBAL LONG READ SEQUENCING MARKET SIZE, BY APPLICATION, 2024 VS 2032 (%)
  • FIGURE 7. GLOBAL LONG READ SEQUENCING MARKET SIZE, BY APPLICATION, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 8. GLOBAL LONG READ SEQUENCING MARKET SIZE, BY END USER, 2024 VS 2032 (%)
  • FIGURE 9. GLOBAL LONG READ SEQUENCING MARKET SIZE, BY END USER, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 10. GLOBAL LONG READ SEQUENCING MARKET SIZE, BY REGION, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 11. AMERICAS LONG READ SEQUENCING MARKET SIZE, BY SUBREGION, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 12. NORTH AMERICA LONG READ SEQUENCING MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 13. LATIN AMERICA LONG READ SEQUENCING MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 14. EUROPE, MIDDLE EAST & AFRICA LONG READ SEQUENCING MARKET SIZE, BY SUBREGION, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 15. EUROPE LONG READ SEQUENCING MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 16. MIDDLE EAST LONG READ SEQUENCING MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 17. AFRICA LONG READ SEQUENCING MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 18. ASIA-PACIFIC LONG READ SEQUENCING MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 19. GLOBAL LONG READ SEQUENCING MARKET SIZE, BY GROUP, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 20. ASEAN LONG READ SEQUENCING MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 21. GCC LONG READ SEQUENCING MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 22. EUROPEAN UNION LONG READ SEQUENCING MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 23. BRICS LONG READ SEQUENCING MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 24. G7 LONG READ SEQUENCING MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 25. NATO LONG READ SEQUENCING MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 26. GLOBAL LONG READ SEQUENCING MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 27. LONG READ SEQUENCING MARKET SHARE, BY KEY PLAYER, 2024
  • FIGURE 28. LONG READ SEQUENCING MARKET, FPNV POSITIONING MATRIX, 2024

LIST OF TABLES

  • TABLE 1. LONG READ SEQUENCING MARKET SEGMENTATION & COVERAGE
  • TABLE 2. UNITED STATES DOLLAR EXCHANGE RATE, 2018-2024
  • TABLE 3. GLOBAL LONG READ SEQUENCING MARKET SIZE, 2018-2024 (USD MILLION)
  • TABLE 4. GLOBAL LONG READ SEQUENCING MARKET SIZE, 2025-2032 (USD MILLION)
  • TABLE 5. GLOBAL LONG READ SEQUENCING MARKET SIZE, BY PRODUCT & SERVICE, 2018-2024 (USD MILLION)
  • TABLE 6. GLOBAL LONG READ SEQUENCING MARKET SIZE, BY PRODUCT & SERVICE, 2025-2032 (USD MILLION)
  • TABLE 7. GLOBAL LONG READ SEQUENCING MARKET SIZE, BY CONSUMABLES, 2018-2024 (USD MILLION)
  • TABLE 8. GLOBAL LONG READ SEQUENCING MARKET SIZE, BY CONSUMABLES, 2025-2032 (USD MILLION)
  • TABLE 9. GLOBAL LONG READ SEQUENCING MARKET SIZE, BY CONSUMABLES, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 10. GLOBAL LONG READ SEQUENCING MARKET SIZE, BY CONSUMABLES, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 11. GLOBAL LONG READ SEQUENCING MARKET SIZE, BY CONSUMABLES, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 12. GLOBAL LONG READ SEQUENCING MARKET SIZE, BY CONSUMABLES, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 13. GLOBAL LONG READ SEQUENCING MARKET SIZE, BY CONSUMABLES, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 14. GLOBAL LONG READ SEQUENCING MARKET SIZE, BY CONSUMABLES, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 15. GLOBAL LONG READ SEQUENCING MARKET SIZE, BY FLOW CELLS, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 16. GLOBAL LONG READ SEQUENCING MARKET SIZE, BY FLOW CELLS, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 17. GLOBAL LONG READ SEQUENCING MARKET SIZE, BY FLOW CELLS, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 18. GLOBAL LONG READ SEQUENCING MARKET SIZE, BY FLOW CELLS, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 19. GLOBAL LONG READ SEQUENCING MARKET SIZE, BY FLOW CELLS, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 20. GLOBAL LONG READ SEQUENCING MARKET SIZE, BY FLOW CELLS, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 21. GLOBAL LONG READ SEQUENCING MARKET SIZE, BY KITS, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 22. GLOBAL LONG READ SEQUENCING MARKET SIZE, BY KITS, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 23. GLOBAL LONG READ SEQUENCING MARKET SIZE, BY KITS, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 24. GLOBAL LONG READ SEQUENCING MARKET SIZE, BY KITS, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 25. GLOBAL LONG READ SEQUENCING MARKET SIZE, BY KITS, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 26. GLOBAL LONG READ SEQUENCING MARKET SIZE, BY KITS, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 27. GLOBAL LONG READ SEQUENCING MARKET SIZE, BY REAGENTS, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 28. GLOBAL LONG READ SEQUENCING MARKET SIZE, BY REAGENTS, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 29. GLOBAL LONG READ SEQUENCING MARKET SIZE, BY REAGENTS, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 30. GLOBAL LONG READ SEQUENCING MARKET SIZE, BY REAGENTS, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 31. GLOBAL LONG READ SEQUENCING MARKET SIZE, BY REAGENTS, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 32. GLOBAL LONG READ SEQUENCING MARKET SIZE, BY REAGENTS, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 33. GLOBAL LONG READ SEQUENCING MARKET SIZE, BY INSTRUMENTS, 2018-2024 (USD MILLION)
  • TABLE 34. GLOBAL LONG READ SEQUENCING MARKET SIZE, BY INSTRUMENTS, 2025-2032 (USD MILLION)
  • TABLE 35. GLOBAL LONG READ SEQUENCING MARKET SIZE, BY INSTRUMENTS, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 36. GLOBAL LONG READ SEQUENCING MARKET SIZE, BY INSTRUMENTS, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 37. GLOBAL LONG READ SEQUENCING MARKET SIZE, BY INSTRUMENTS, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 38. GLOBAL LONG READ SEQUENCING MARKET SIZE, BY INSTRUMENTS, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 39. GLOBAL LONG READ SEQUENCING MARKET SIZE, BY INSTRUMENTS, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 40. GLOBAL LONG READ SEQUENCING MARKET SIZE, BY INSTRUMENTS, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 41. GLOBAL LONG READ SEQUENCING MARKET SIZE, BY ACCESSORIES, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 42. GLOBAL LONG READ SEQUENCING MARKET SIZE, BY ACCESSORIES, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 43. GLOBAL LONG READ SEQUENCING MARKET SIZE, BY ACCESSORIES, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 44. GLOBAL LONG READ SEQUENCING MARKET SIZE, BY ACCESSORIES, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 45. GLOBAL LONG READ SEQUENCING MARKET SIZE, BY ACCESSORIES, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 46. GLOBAL LONG READ SEQUENCING MARKET SIZE, BY ACCESSORIES, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 47. GLOBAL LONG READ SEQUENCING MARKET SIZE, BY SEQUENCING SYSTEMS, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 48. GLOBAL LONG READ SEQUENCING MARKET SIZE, BY SEQUENCING SYSTEMS, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 49. GLOBAL LONG READ SEQUENCING MARKET SIZE, BY SEQUENCING SYSTEMS, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 50. GLOBAL LONG READ SEQUENCING MARKET SIZE, BY SEQUENCING SYSTEMS, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 51. GLOBAL LONG READ SEQUENCING MARKET SIZE, BY SEQUENCING SYSTEMS, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 52. GLOBAL LONG READ SEQUENCING MARKET SIZE, BY SEQUENCING SYSTEMS, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 53. GLOBAL LONG READ SEQUENCING MARKET SIZE, BY SOFTWARE & SERVICES, 2018-2024 (USD MILLION)
  • TABLE 54. GLOBAL LONG READ SEQUENCING MARKET SIZE, BY SOFTWARE & SERVICES, 2025-2032 (USD MILLION)
  • TABLE 55. GLOBAL LONG READ SEQUENCING MARKET SIZE, BY SOFTWARE & SERVICES, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 56. GLOBAL LONG READ SEQUENCING MARKET SIZE, BY SOFTWARE & SERVICES, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 57. GLOBAL LONG READ SEQUENCING MARKET SIZE, BY SOFTWARE & SERVICES, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 58. GLOBAL LONG READ SEQUENCING MARKET SIZE, BY SOFTWARE & SERVICES, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 59. GLOBAL LONG READ SEQUENCING MARKET SIZE, BY SOFTWARE & SERVICES, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 60. GLOBAL LONG READ SEQUENCING MARKET SIZE, BY SOFTWARE & SERVICES, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 61. GLOBAL LONG READ SEQUENCING MARKET SIZE, BY BIOINFORMATICS SERVICES, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 62. GLOBAL LONG READ SEQUENCING MARKET SIZE, BY BIOINFORMATICS SERVICES, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 63. GLOBAL LONG READ SEQUENCING MARKET SIZE, BY BIOINFORMATICS SERVICES, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 64. GLOBAL LONG READ SEQUENCING MARKET SIZE, BY BIOINFORMATICS SERVICES, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 65. GLOBAL LONG READ SEQUENCING MARKET SIZE, BY BIOINFORMATICS SERVICES, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 66. GLOBAL LONG READ SEQUENCING MARKET SIZE, BY BIOINFORMATICS SERVICES, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 67. GLOBAL LONG READ SEQUENCING MARKET SIZE, BY DATA ANALYSIS SOFTWARE, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 68. GLOBAL LONG READ SEQUENCING MARKET SIZE, BY DATA ANALYSIS SOFTWARE, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 69. GLOBAL LONG READ SEQUENCING MARKET SIZE, BY DATA ANALYSIS SOFTWARE, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 70. GLOBAL LONG READ SEQUENCING MARKET SIZE, BY DATA ANALYSIS SOFTWARE, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 71. GLOBAL LONG READ SEQUENCING MARKET SIZE, BY DATA ANALYSIS SOFTWARE, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 72. GLOBAL LONG READ SEQUENCING MARKET SIZE, BY DATA ANALYSIS SOFTWARE, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 73. GLOBAL LONG READ SEQUENCING MARKET SIZE, BY MAINTENANCE SERVICES, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 74. GLOBAL LONG READ SEQUENCING MARKET SIZE, BY MAINTENANCE SERVICES, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 75. GLOBAL LONG READ SEQUENCING MARKET SIZE, BY MAINTENANCE SERVICES, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 76. GLOBAL LONG READ SEQUENCING MARKET SIZE, BY MAINTENANCE SERVICES, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 77. GLOBAL LONG READ SEQUENCING MARKET SIZE, BY MAINTENANCE SERVICES, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 78. GLOBAL LONG READ SEQUENCING MARKET SIZE, BY MAINTENANCE SERVICES, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 79. GLOBAL LONG READ SEQUENCING MARKET SIZE, BY TECHNOLOGY, 2018-2024 (USD MILLION)
  • TABLE 80. GLOBAL LONG READ SEQUENCING MARKET SIZE, BY TECHNOLOGY, 2025-2032 (USD MILLION)
  • TABLE 81. GLOBAL LONG READ SEQUENCING MARKET SIZE, BY NANOPORE SEQUENCING, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 82. GLOBAL LONG READ SEQUENCING MARKET SIZE, BY NANOPORE SEQUENCING, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 83. GLOBAL LONG READ SEQUENCING MARKET SIZE, BY NANOPORE SEQUENCING, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 84. GLOBAL LONG READ SEQUENCING MARKET SIZE, BY NANOPORE SEQUENCING, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 85. GLOBAL LONG READ SEQUENCING MARKET SIZE, BY NANOPORE SEQUENCING, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 86. GLOBAL LONG READ SEQUENCING MARKET SIZE, BY NANOPORE SEQUENCING, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 87. GLOBAL LONG READ SEQUENCING MARKET SIZE, BY SINGLE MOLECULE REAL TIME SEQUENCING, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 88. GLOBAL LONG READ SEQUENCING MARKET SIZE, BY SINGLE MOLECULE REAL TIME SEQUENCING, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 89. GLOBAL LONG READ SEQUENCING MARKET SIZE, BY SINGLE MOLECULE REAL TIME SEQUENCING, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 90. GLOBAL LONG READ SEQUENCING MARKET SIZE, BY SINGLE MOLECULE REAL TIME SEQUENCING, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 91. GLOBAL LONG READ SEQUENCING MARKET SIZE, BY SINGLE MOLECULE REAL TIME SEQUENCING, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 92. GLOBAL LONG READ SEQUENCING MARKET SIZE, BY SINGLE MOLECULE REAL TIME SEQUENCING, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 93. GLOBAL LONG READ SEQUENCING MARKET SIZE, BY SYNTHETIC LONG READ SEQUENCING, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 94. GLOBAL LONG READ SEQUENCING MARKET SIZE, BY SYNTHETIC LONG READ SEQUENCING, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 95. GLOBAL LONG READ SEQUENCING MARKET SIZE, BY SYNTHETIC LONG READ SEQUENCING, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 96. GLOBAL LONG READ SEQUENCING MARKET SIZE, BY SYNTHETIC LONG READ SEQUENCING, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 97. GLOBAL LONG READ SEQUENCING MARKET SIZE, BY SYNTHETIC LONG READ SEQUENCING, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 98. GLOBAL LONG READ SEQUENCING MARKET SIZE, BY SYNTHETIC LONG READ SEQUENCING, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 99. GLOBAL LONG READ SEQUENCING MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
  • TABLE 100. GLOBAL LONG READ SEQUENCING MARKET SIZE, BY APPLICATION, 2025-2032 (USD MILLION)
  • TABLE 101. GLOBAL LONG READ SEQUENCING MARKET SIZE, BY AGRICULTURAL GENOMICS, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 102. GLOBAL LONG READ SEQUENCING MARKET SIZE, BY AGRICULTURAL GENOMICS, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 103. GLOBAL LONG READ SEQUENCING MARKET SIZE, BY AGRICULTURAL GENOMICS, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 104. GLOBAL LONG READ SEQUENCING MARKET SIZE, BY AGRICULTURAL GENOMICS, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 105. GLOBAL LONG READ SEQUENCING MARKET SIZE, BY AGRICULTURAL GENOMICS, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 106. GLOBAL LONG READ SEQUENCING MARKET SIZE, BY AGRICULTURAL GENOMICS, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 107. GLOBAL LONG READ SEQUENCING MARKET SIZE, BY CANCER GENOMICS, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 108. GLOBAL LONG READ SEQUENCING MARKET SIZE, BY CANCER GENOMICS, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 109. GLOBAL LONG READ SEQUENCING MARKET SIZE, BY CANCER GENOMICS, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 110. GLOBAL LONG READ SEQUENCING MARKET SIZE, BY CANCER GENOMICS, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 111. GLOBAL LONG READ SEQUENCING MARKET SIZE, BY CANCER GENOMICS, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 112. GLOBAL LONG READ SEQUENCING MARKET SIZE, BY CANCER GENOMICS, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 113. GLOBAL LONG READ SEQUENCING MARKET SIZE, BY CLINICAL RESEARCH, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 114. GLOBAL LONG READ SEQUENCING MARKET SIZE, BY CLINICAL RESEARCH, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 115. GLOBAL LONG READ SEQUENCING MARKET SIZE, BY CLINICAL RESEARCH, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 116. GLOBAL LONG READ SEQUENCING MARKET SIZE, BY CLINICAL RESEARCH, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 117. GLOBAL LONG READ SEQUENCING MARKET SIZE, BY CLINICAL RESEARCH, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 118. GLOBAL LONG READ SEQUENCING MARKET SIZE, BY CLINICAL RESEARCH, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 119. GLOBAL LONG READ SEQUENCING MARKET SIZE, BY MICROBIAL GENOMICS, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 120. GLOBAL LONG READ SEQUENCING MARKET SIZE, BY MICROBIAL GENOMICS, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 121. GLOBAL LONG READ SEQUENCING MARKET SIZE, BY MICROBIAL GENOMICS, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 122. GLOBAL LONG READ SEQUENCING MARKET SIZE, BY MICROBIAL GENOMICS, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 123. GLOBAL LONG READ SEQUENCING MARKET SIZE, BY MICROBIAL GENOMICS, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 124. GLOBAL LONG READ SEQUENCING MARKET SIZE, BY MICROBIAL GENOMICS, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 125. GLOBAL LONG READ SEQUENCING MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
  • TABLE 126. GLOBAL LONG READ SEQUENCING MARKET SIZE, BY END USER, 2025-2032 (USD MILLION)
  • TABLE 127. GLOBAL LONG READ SEQUENCING MARKET SIZE, BY ACADEMIC, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 128. GLOBAL LONG READ SEQUENCING MARKET SIZE, BY ACADEMIC, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 129. GLOBAL LONG READ SEQUENCING MARKET SIZE, BY ACADEMIC, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 130. GLOBAL LONG READ SEQUENCING MARKET SIZE, BY ACADEMIC, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 131. GLOBAL LONG READ SEQUENCING MARKET SIZE, BY ACADEMIC, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 132. GLOBAL LONG READ SEQUENCING MARKET SIZE, BY ACADEMIC, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 133. GLOBAL LONG READ SEQUENCING MARKET SIZE, BY CLINICAL DIAGNOSTIC LABORATORIES, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 134. GLOBAL LONG READ SEQUENCING MARKET SIZE, BY CLINICAL DIAGNOSTIC LABORATORIES, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 135. GLOBAL LONG READ SEQUENCING MARKET SIZE, BY CLINICAL DIAGNOSTIC LABORATORIES, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 136. GLOBAL LONG READ SEQUENCING MARKET SIZE, BY CLINICAL DIAGNOSTIC LABORATORIES, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 137. GLOBAL LONG READ SEQUENCING MARKET SIZE, BY CLINICAL DIAGNOSTIC LABORATORIES, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 138. GLOBAL LONG READ SEQUENCING MARKET SIZE, BY CLINICAL DIAGNOSTIC LABORATORIES, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 139. GLOBAL LONG READ SEQUENCING MARKET SIZE, BY CONTRACT RESEARCH ORGANIZATIONS, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 140. GLOBAL LONG READ SEQUENCING MARKET SIZE, BY CONTRACT RESEARCH ORGANIZATIONS, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 141. GLOBAL LONG READ SEQUENCING MARKET SIZE, BY CONTRACT RESEARCH ORGANIZATIONS, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 142. GLOBAL LONG READ SEQUENCING MARKET SIZE, BY CONTRACT RESEARCH ORGANIZATIONS, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 143. GLOBAL LONG READ SEQUENCING MARKET SIZE, BY CONTRACT RESEARCH ORGANIZATIONS, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 144. GLOBAL LONG READ SEQUENCING MARKET SIZE, BY CONTRACT RESEARCH ORGANIZATIONS, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 145. GLOBAL LONG READ SEQUENCING MARKET SIZE, BY GOVERNMENT AND REGULATORY BODIES, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 146. GLOBAL LONG READ SEQUENCING MARKET SIZE, BY GOVERNMENT AND REGULATORY BODIES, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 147. GLOBAL LONG READ SEQUENCING MARKET SIZE, BY GOVERNMENT AND REGULATORY BODIES, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 148. GLOBAL LONG READ SEQUENCING MARKET SIZE, BY GOVERNMENT AND REGULATORY BODIES, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 149. GLOBAL LONG READ SEQUENCING MARKET SIZE, BY GOVERNMENT AND REGULATORY BODIES, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 150. GLOBAL LONG READ SEQUENCING MARKET SIZE, BY GOVERNMENT AND REGULATORY BODIES, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 151. GLOBAL LONG READ SEQUENCING MARKET SIZE, BY PHARMACEUTICAL AND BIOTECHNOLOGY, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 152. GLOBAL LONG READ SEQUENCING MARKET SIZE, BY PHARMACEUTICAL AND BIOTECHNOLOGY, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 153. GLOBAL LONG READ SEQUENCING MARKET SIZE, BY PHARMACEUTICAL AND BIOTECHNOLOGY, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 154. GLOBAL LONG READ SEQUENCING MARKET SIZE, BY PHARMACEUTICAL AND BIOTECHNOLOGY, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 155. GLOBAL LONG READ SEQUENCING MARKET SIZE, BY PHARMACEUTICAL AND BIOTECHNOLOGY, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 156. GLOBAL LONG READ SEQUENCING MARKET SIZE, BY PHARMACEUTICAL AND BIOTECHNOLOGY, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 157. GLOBAL LONG READ SEQUENCING MARKET SIZE, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 158. GLOBAL LONG READ SEQUENCING MARKET SIZE, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 159. AMERICAS LONG READ SEQUENCING MARKET SIZE, BY SUBREGION, 2018-2024 (USD MILLION)
  • TABLE 160. AMERICAS LONG READ SEQUENCING MARKET SIZE, BY SUBREGION, 2025-2032 (USD MILLION)
  • TABLE 161. AMERICAS LONG READ SEQUENCING MARKET SIZE, BY PRODUCT & SERVICE, 2018-2024 (USD MILLION)
  • TABLE 162. AMERICAS LONG READ SEQUENCING MARKET SIZE, BY PRODUCT & SERVICE, 2025-2032 (USD MILLION)
  • TABLE 163. AMERICAS LONG READ SEQUENCING MARKET SIZE, BY CONSUMABLES, 2018-2024 (USD MILLION)
  • TABLE 164. AMERICAS LONG READ SEQUENCING MARKET SIZE, BY CONSUMABLES, 2025-2032 (USD MILLION)
  • TABLE 165. AMERICAS LONG READ SEQUENCING MARKET SIZE, BY INSTRUMENTS, 2018-2024 (USD MILLION)
  • TABLE 166. AMERICAS LONG READ SEQUENCING MARKET SIZE, BY INSTRUMENTS, 2025-2032 (USD MILLION)
  • TABLE 167. AMERICAS LONG READ SEQUENCING MARKET SIZE, BY SOFTWARE & SERVICES, 2018-2024 (USD MILLION)
  • TABLE 168. AMERICAS LONG READ SEQUENCING MARKET SIZE, BY SOFTWARE & SERVICES, 2025-2032 (USD MILLION)
  • TABLE 169. AMERICAS LONG READ SEQUENCING MARKET SIZE, BY TECHNOLOGY, 2018-2024 (USD MILLION)
  • TABLE 170. AMERICAS LONG READ SEQUENCING MARKET SIZE, BY TECHNOLOGY, 2025-2032 (USD MILLION)
  • TABLE 171. AMERICAS LONG READ SEQUENCING MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
  • TABLE 172. AMERICAS LONG READ SEQUENCING MARKET SIZE, BY APPLICATION, 2025-2032 (USD MILLION)
  • TABLE 173. AMERICAS LONG READ SEQUENCING MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
  • TABLE 174. AMERICAS LONG READ SEQUENCING MARKET SIZE, BY END USER, 2025-2032 (USD MILLION)
  • TABLE 175. NORTH AMERICA LONG READ SEQUENCING MARKET SIZE, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 176. NORTH AMERICA LONG READ SEQUENCING MARKET SIZE, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 177. NORTH AMERICA LONG READ SEQUENCING MARKET SIZE, BY PRODUCT & SERVICE, 2018-2024 (USD MILLION)
  • TABLE 178. NORTH AMERICA LONG READ SEQUENCING MARKET SIZE, BY PRODUCT & SERVICE, 2025-2032 (USD MILLION)
  • TABLE 179. NORTH AMERICA LONG READ SEQUENCING MARKET SIZE, BY CONSUMABLES, 2018-2024 (USD MILLION)
  • TABLE 180. NORTH AMERICA LONG READ SEQUENCING MARKET SIZE, BY CONSUMABLES, 2025-2032 (USD MILLION)
  • TABLE 181. NORTH AMERICA LONG READ SEQUENCING MARKET SIZE, BY INSTRUMENTS, 2018-2024 (USD MILLION)
  • TABLE 182. NORTH AMERICA LONG READ SEQUENCING MARKET SIZE, BY INSTRUMENTS, 2025-2032 (USD MILLION)
  • TABLE 183. NORTH AMERICA LONG READ SEQUENCING MARKET SIZE, BY SOFTWARE & SERVICES, 2018-2024 (USD MILLION)
  • TABLE 184. NORTH AMERICA LONG READ SEQUENCING MARKET SIZE, BY SOFTWARE & SERVICES, 2025-2032 (USD MILLION)
  • TABLE 185. NORTH AMERICA LONG READ SEQUENCING MARKET SIZE, BY TECHNOLOGY, 2018-2024 (USD MILLION)
  • TABLE 186. NORTH AMERICA LONG READ SEQUENCING MARKET SIZE, BY TECHNOLOGY, 2025-2032 (USD MILLION)
  • TABLE 187. NORTH AMERICA LONG READ SEQUENCING MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
  • TABLE 188. NORTH AMERICA LONG READ SEQUENCING MARKET SIZE, BY APPLICATION, 2025-2032 (USD MILLION)
  • TABLE 189. NORTH AMERICA LONG READ SEQUENCING MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
  • TABLE 190. NORTH AMERICA LONG READ SEQUENCING MARKET SIZE, BY END USER, 2025-2032 (USD MILLION)
  • TABLE 191. LATIN AMERICA LONG READ SEQUENCING MARKET SIZE, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 192. LATIN AMERICA LONG READ SEQUENCING MARKET SIZE, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 193. LATIN AMERICA LONG READ SEQUENCING MARKET SIZE, BY PRODUCT & SERVICE, 2018-2024 (USD MILLION)
  • TABLE 194. LATIN AMERICA LONG READ SEQUENCING MARKET SIZE, BY PRODUCT & SERVICE, 2025-2032 (USD MILLION)
  • TABLE 195. LATIN AMERICA LONG READ SEQUENCING MARKET SIZE, BY CONSUMABLES, 2018-2024 (USD MILLION)
  • TABLE 196. LATIN AMERICA LONG READ SEQUENCING MARKET SIZE, BY CONSUMABLES, 2025-2032 (USD MILLION)
  • TABLE 197. LATIN AMERICA LONG READ SEQUENCING MARKET SIZE, BY INSTRUMENTS, 2018-2024 (USD MILLION)
  • TABLE 198. LATIN AMERICA LONG READ SEQUENCING MARKET SIZE, BY INSTRUMENTS, 2025-2032 (USD MILLION)
  • TABLE 199. LATIN AMERICA LONG READ SEQUENCING MARKET SIZE, BY SOFTWARE & SERVICES, 2018-2024 (USD MILLION)
  • TABLE 200. LATIN AMERICA LONG READ SEQUENCING MARKET SIZE, BY SOFTWARE & SERVICES, 2025-2032 (USD MILLION)
  • TABLE 201. LATIN AMERICA LONG READ SEQUENCING MARKET SIZE, BY TECHNOLOGY, 2018-2024 (USD MILLION)
  • TABLE 202. LATIN AMERICA LONG READ SEQUENCING MARKET SIZE, BY TECHNOLOGY, 2025-2032 (USD MILLION)
  • TABLE 203. LATIN AMERICA LONG READ SEQUENCING MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
  • TABLE 204. LATIN AMERICA LONG READ SEQUENCING MARKET SIZE, BY APPLICATION, 2025-2032 (USD MILLION)
  • TABLE 205. LATIN AMERICA LONG READ SEQUENCING MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
  • TABLE 206. LATIN AMERICA LONG READ SEQUENCING MARKET SIZE, BY END USER, 2025-2032 (USD MILLION)
  • TABLE 207. EUROPE, MIDDLE EAST & AFRICA LONG READ SEQUENCING MARKET SIZE, BY SUBREGION, 2018-2024 (USD MILLION)
  • TABLE 208. EUROPE, MIDDLE EAST & AFRICA LONG READ SEQUENCING MARKET SIZE, BY SUBREGION, 2025-2032 (USD MILLION)
  • TABLE 209. EUROPE, MIDDLE EAST & AFRICA LONG READ SEQUENCING MARKET SIZE, BY PRODUCT & SERVICE, 2018-2024 (USD MILLION)
  • TABLE 210. EUROPE, MIDDLE EAST & AFRICA LONG READ SEQUENCING MARKET SIZE, BY PRODUCT & SERVICE, 2025-2032 (USD MILLION)
  • TABLE 211. EUROPE, MIDDLE EAST & AFRICA LONG READ SEQUENCING MARKET SIZE, BY CONSUMABLES, 2018-2024 (USD MILLION)
  • TABLE 212. EUROPE, MIDDLE EAST & AFRICA LONG READ SEQUENCING MARKET SIZE, BY CONSUMABLES, 2025-2032 (USD MILLION)
  • TABLE 213. EUROPE, MIDDLE EAST & AFRICA LONG READ SEQUENCING MARKET SIZE, BY INSTRUMENTS, 2018-2024 (USD MILLION)
  • TABLE 214. EUROPE, MIDDLE EAST & AFRICA LONG READ SEQUENCING MARKET SIZE, BY INSTRUMENTS, 2025-2032 (USD MILLION)
  • TABLE 215. EUROPE, MIDDLE EAST & AFRICA LONG READ SEQUENCING MARKET SIZE, BY SOFTWARE & SERVICES, 2018-2024 (USD MILLION)
  • TABLE 216. EUROPE, MIDDLE EAST & AFRICA LONG READ SEQUENCING MARKET SIZE, BY SOFTWARE & SERVICES, 2025-2032 (USD MILLION)
  • TABLE 217. EUROPE, MIDDLE EAST & AFRICA LONG READ SEQUENCING MARKET SIZE, BY TECHNOLOGY, 2018-2024 (USD MILLION)
  • TABLE 218. EUROPE, MIDDLE EAST & AFRICA LONG READ SEQUENCING MARKET SIZE, BY TECHNOLOGY, 2025-2032 (USD MILLION)
  • TABLE 219. EUROPE, MIDDLE EAST & AFRICA LONG READ SEQUENCING MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
  • TABLE 220. EUROPE, MIDDLE EAST & AFRICA LONG READ SEQUENCING MARKET SIZE, BY APPLICATION, 2025-2032 (USD MILLION)
  • TABLE 221. EUROPE, MIDDLE EAST & AFRICA LONG READ SEQUENCING MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
  • TABLE 222. EUROPE, MIDDLE EAST & AFRICA LONG READ SEQUENCING MARKET SIZE, BY END USER, 2025-2032 (USD MILLION)
  • TABLE 223. EUROPE LONG READ SEQUENCING MARKET SIZE, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 224. EUROPE LONG READ SEQUENCING MARKET SIZE, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 225. EUROPE LONG READ SEQUENCING MARKET SIZE, BY PRODUCT & SERVICE, 2018-2024 (USD MILLION)
  • TABLE 226. EUROPE LONG READ SEQUENCING MARKET SIZE, BY PRODUCT & SERVICE, 2025-2032 (USD MILLION)
  • TABLE 227. EUROPE LONG READ SEQUENCING MARKET SIZE, BY CONSUMABLES, 2018-2024 (USD MILLION)
  • TABLE 228. EUROPE LONG READ SEQUENCING MARKET SIZE, BY CONSUMABLES, 2025-2032 (USD MILLION)
  • TABLE 229. EUROPE LONG READ SEQUENCING MARKET SIZE, BY INSTRUMENTS, 2018-2024 (USD MILLION)
  • TABLE 230. EUROPE LONG READ SEQUENCING MARKET SIZE, BY INSTRUMENTS, 2025-2032 (USD MILLION)
  • TABLE 231. EUROPE LONG READ SEQUENCING MARKET SIZE, BY SOFTWARE & SERVICES, 2018-2024 (USD MILLION)
  • TABLE 232. EUROPE LONG READ SEQUENCING MARKET SIZE, BY SOFTWARE & SERVICES, 2025-2032 (USD MILLION)
  • TABLE 233. EUROPE LONG READ SEQUENCING MARKET SIZE, BY TECHNOLOGY, 2018-2024 (USD MILLION)
  • TABLE 234. EUROPE LONG READ SEQUENCING MARKET SIZE, BY TECHNOLOGY, 2025-2032 (USD MILLION)
  • TABLE 235. EUROPE LONG READ SEQUENCING MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
  • TABLE 236. EUROPE LONG READ SEQUENCING MARKET SIZE, BY APPLICATION, 2025-2032 (USD MILLION)
  • TABLE 237. EUROPE LONG READ SEQUENCING MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
  • TABLE 238. EUROPE LONG READ SEQUENCING MARKET SIZE, BY END USER, 2025-2032 (USD MILLION)
  • TABLE 239. MIDDLE EAST LONG READ SEQUENCING MARKET SIZE, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 240. MIDDLE EAST LONG READ SEQUENCING MARKET SIZE, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 241. MIDDLE EAST LONG READ SEQUENCING MARKET SIZE, BY PRODUCT & SERVICE, 2018-2024 (USD MILLION)
  • TABLE 242. MIDDLE EAST LONG READ SEQUENCING MARKET SIZE, BY PRODUCT & SERVICE, 2025-2032 (USD MILLION)
  • TABLE 243. MIDDLE EAST LONG READ SEQUENCING MARKET SIZE, BY CONSUMABLES, 2018-2024 (USD MILLION)
  • TABLE 244. MIDDLE EAST LONG READ SEQUENCING MARKET SIZE, BY CONSUMABLES, 2025-2032 (USD MILLION)
  • TABLE 245. MIDDLE EAST LONG READ SEQUENCING MARKET SIZE, BY INSTRUMENTS, 2018-2024 (USD MILLION)
  • TABLE 246. MIDDLE EAST LONG READ SEQUENCING MARKET SIZE, BY INSTRUMENTS, 2025-2032 (USD MILLION)
  • TABLE 247. MIDDLE EAST LONG READ SEQUENCING MARKET SIZE, BY SOFTWARE & SERVICES, 2018-2024 (USD MILLION)
  • TABLE 248. MIDDLE EAST LONG READ SEQUENCING MARKET SIZE, BY SOFTWARE & SERVICES, 2025-2032 (USD MILLION)
  • TABLE 249. MIDDLE EAST LONG READ SEQUENCING MARKET SIZE, BY TECHNOLOGY, 2018-2024 (USD MILLION)
  • TABLE 250. MIDDLE EAST LONG READ SEQUENCING MARKET SIZE, BY TECHNOLOGY, 2025-2032 (USD MILLION)
  • TABLE 251. MIDDLE EAST LONG READ SEQUENCING MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
  • TABLE 252. MIDDLE EAST LONG READ SEQUENCING MARKET SIZE, BY APPLICATION, 2025-2032 (USD MILLION)
  • TABLE 253. MIDDLE EAST LONG READ SEQUENCING MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
  • TABLE 254. MIDDLE EAST LONG READ SEQUENCING MARKET SIZE, BY END USER, 2025-2032 (USD MILLION)
  • TABLE 255. AFRICA LONG READ SEQUENCING MARKET SIZE, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 256. AFRICA LONG READ SEQUENCING MARKET SIZE, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 257. AFRICA LONG READ SEQUENCING MARKET SIZE, BY PRODUCT & SERVICE, 2018-2024 (USD MILLION)
  • TABLE 258. AFRICA LONG READ SEQUENCING MARKET SIZE, BY PRODUCT & SERVICE, 2025-2032 (USD MILLION)
  • TABLE 259. AFRICA LONG READ SEQUENCING MARKET SIZE, BY CONSUMABLES, 2018-2024 (USD MILLION)
  • TABLE 260. AFRICA LONG READ SEQUENCING MARKET SIZE, BY CONSUMABLES, 2025-2032 (USD MILLION)
  • TABLE 261. AFRICA LONG READ SEQUENCING MARKET SIZE, BY INSTRUMENTS, 2018-2024 (USD MILLION)
  • TABLE 262. AFRICA LONG READ SEQUENCING MARKET SIZE, BY INSTRUMENTS, 2025-2032 (USD MILLION)
  • TABLE 263. AFRICA LONG READ SEQUENCING MARKET SIZE, BY SOFTWARE & SERVICES, 2018-2024 (USD MILLION)
  • TABLE 264. AFRICA LONG READ SEQUENCING MARKET SIZE, BY SOFTWARE & SERVICES, 2025-2032 (USD MILLION)
  • TABLE 265. AFRICA LONG READ SEQUENCING MARKET SIZE, BY TECHNOLOGY, 2018-2024 (USD MILLION)
  • TABLE 266. AFRICA LONG READ SEQUENCING MARKET SIZE, BY TECHNOLOGY, 2025-2032 (USD MILLION)
  • TABLE 267. AFRICA LONG READ SEQUENCING MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
  • TABLE 268. AFRICA LONG READ SEQUENCING MARKET SIZE, BY APPLICATION, 2025-2032 (USD MILLION)
  • TABLE 269. AFRICA LONG READ SEQUENCING MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
  • TABLE 270. AFRICA LONG READ SEQUENCING MARKET SIZE, BY END USER, 2025-2032 (USD MILLION)
  • TABLE 271. ASIA-PACIFIC LONG READ SEQUENCING MARKET SIZE, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 272. ASIA-PACIFIC LONG READ SEQUENCING MARKET SIZE, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 273. ASIA-PACIFIC LONG READ SEQUENCING MARKET SIZE, BY PRODUCT & SERVICE, 2018-2024 (USD MILLION)
  • TABLE 274. ASIA-PACIFIC LONG READ SEQUENCING MARKET SIZE, BY PRODUCT & SERVICE, 2025-2032 (USD MILLION)
  • TABLE 275. ASIA-PACIFIC LONG READ SEQUENCING MARKET SIZE, BY CONSUMABLES, 2018-2024 (USD MILLION)
  • TABLE 276. ASIA-PACIFIC LONG READ SEQUENCING MARKET SIZE, BY CONSUMABLES, 2025-2032 (USD MILLION)
  • TABLE 277. ASIA-PACIFIC LONG READ SEQUENCING MARKET SIZE, BY INSTRUMENTS, 2018-2024 (USD MILLION)
  • TABLE 278. ASIA-PACIFIC LONG READ SEQUENCING MARKET SIZE, BY INSTRUMENTS, 2025-2032 (USD MILLION)
  • TABLE 279. ASIA-PACIFIC LONG READ SEQUENCING MARKET SIZE, BY SOFTWARE & SERVICES, 2018-2024 (USD MILLION)
  • TABLE 280. ASIA-PACIFIC LONG READ SEQUENCING MARKET SIZE, BY SOFTWARE & SERVICES, 2025-2032 (USD MILLION)
  • TABLE 281. ASIA-PACIFIC LONG READ SEQUENCING MARKET SIZE, BY TECHNOLOGY, 2018-2024 (USD MILLION)
  • TABLE 282. ASIA-PACIFIC LONG READ SEQUENCING MARKET SIZE, BY TECHNOLOGY, 2025-2032 (USD MILLION)
  • TABLE 283. ASIA-PACIFIC LONG READ SEQUENCING MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
  • TABLE 284. ASIA-PACIFIC LONG READ SEQUENCING MARKET SIZE, BY APPLICATION, 2025-2032 (USD MILLION)
  • TABLE 285. ASIA-PACIFIC LONG READ SEQUENCING MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
  • TABLE 286. ASIA-PACIFIC LONG READ SEQUENCING MARKET SIZE, BY END USER, 2025-2032 (USD MILLION)
  • TABLE 287. GLOBAL LONG READ SEQUENCING MARKET SIZE, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 288. GLOBAL LONG READ SEQUENCING MARKET SIZE, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 289. ASEAN LONG READ SEQUENCING MARKET SIZE, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 290. ASEAN LONG READ SEQUENCING MARKET SIZE, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 291. ASEAN LONG READ SEQUENCING MARKET SIZE, BY PRODUCT & SERVICE, 2018-2024 (USD MILLION)
  • TABLE 292. ASEAN LONG READ SEQUENCING MARKET SIZE, BY PRODUCT & SERVICE, 2025-2032 (USD MILLION)
  • TABLE 293. ASEAN LONG READ SEQUENCING MARKET SIZE, BY CONSUMABLES, 2018-2024 (USD MILLION)
  • TABLE 294. ASEAN LONG READ SEQUENCING MARKET SIZE, BY CONSUMABLES, 2025-2032 (USD MILLION)
  • TABLE 295. ASEAN LONG READ SEQUENCING MARKET SIZE, BY INSTRUMENTS, 2018-2024 (USD MILLION)
  • TABLE 296. ASEAN LONG READ SEQUENCING MARKET SIZE, BY INSTRUMENTS, 2025-2032 (USD MILLION)
  • TABLE 297. ASEAN LONG READ SEQUENCING MARKET SIZE, BY SOFTWARE & SERVICES, 2018-2024 (USD MILLION)
  • TABLE 298. ASEAN LONG READ SEQUENCING MARKET SIZE, BY SOFTWARE & SERVICES, 2025-2032 (USD MILLION)
  • TABLE 299. ASEAN LONG READ SEQUENCING MARKET SIZE, BY TECHNOLOGY, 2018-2024 (USD MILLION)
  • TABLE 300. ASEAN LONG READ SEQUENCING MARKET SIZE, BY TECHNOLOGY, 2025-2032 (USD MILLION)
  • TABLE 301. ASEAN LONG READ SEQUENCING MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
  • TABLE 302. ASEAN LONG READ SEQUENCING MARKET SIZE, BY APPLICATION, 2025-2032 (USD MILLION)
  • TABLE 303. ASEAN LONG READ SEQUENCING MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
  • TABLE 304. ASEAN LONG READ SEQUENCING MARKET SIZE, BY END USER, 2025-2032 (USD MILLION)
  • TABLE 305. GCC LONG READ SEQUENCING MARKET SIZE, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 306. GCC LONG READ SEQUENCING MARKET SIZE, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 307. GCC LONG READ SEQUENCING MARKET SIZE, BY PRODUCT & SERVICE, 2018-2024 (USD MILLION)
  • TABLE 308. GCC LONG READ SEQUENCING MARKET SIZE, BY PRODUCT & SERVICE, 2025-2032 (USD MILLION)
  • TABLE 309. GCC LONG READ SEQUENCING MARKET SIZE, BY CONSUMABLES, 2018-2024 (USD MILLION)
  • TABLE 310. GCC LONG READ SEQUENCING MARKET SIZE, BY CONSUMABLES, 2025-2032 (USD MILLION)
  • TABLE 311. GCC LONG READ SEQUENCING MARKET SIZE, BY INSTRUMENTS, 2018-2024 (USD MILLION)
  • TABLE 312. GCC LONG READ SEQUENCING MARKET SIZE, BY INSTRUMENTS, 2025-2032 (USD MILLION)
  • TABLE 313. GCC LONG READ SEQUENCING MARKET SIZE, BY SOFTWARE & SERVICES, 2018-2024 (USD MILLION)
  • TABLE 314. GCC LONG READ SEQUENCING MARKET SIZE, BY SOFTWARE & SERVICES, 2025-2032 (USD MILLION)
  • TABLE 315. GCC LONG READ SEQUENCING MARKET SIZE, BY TECHNOLOGY, 2018-2024 (USD MILLION)
  • TABLE 316. GCC LONG READ SEQUENCING MARKET SIZE, BY TECHNOLOGY, 2025-2032 (USD MILLION)
  • TABLE 317. GCC LONG READ SEQUENCING MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
  • TABLE 318. GCC LONG READ SEQUENCING MARKET SIZE, BY APPLICATION, 2025-2032 (USD MILLION)
  • TABLE 319. GCC LONG READ SEQUENCING MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
  • TABLE 320. GCC LONG READ SEQUENCING MARKET SIZE, BY END USER, 2025-2032 (USD MILL